Philip Hinds, PhD, Program Director
The MS in Biomedical Management Program is directed by Philip Hinds, PhD. Dr. Hinds received his PhD in Molecular Biology from Princeton University and completed postdoctoral Training at the Whitehead Institute at MIT. He joined the faculty at Tufts in 2014 and has served in numerous leadership roles since that time, including Chair of the Department of Developmental, Molecular & Chemical Biology at Tufts University School of Medicine and Deputy Director of the Tufts Cancer Center. He is a member of the GSBS programs in Cell, Molecular & Developmental Biology and Genetics.
Dr. Hinds' research focuses on preclinical models of cellular proliferation control and its dysregulation in cancer cells with a particular interest in melanoma. He is also interested in mechanisms of cell cycle control including pathways modulated by the retinoblastoma protein (pRB), D-type cyclins, cdk4 and cdk6.
Dr. Hinds has long been engaged in working with the biotechnology industry and currently serves as chair of the board of advisors for ExGloH and as a consultant for Incyte. Many of Dr. Hinds’ students have obtained positions in a wide variety of biotech and pharma companies, including Agios, BioAgilytix, bluebird bio, Leidos, Nuvation Bio, and Sartorius Stedim.
Andrew Bohm, PhD, Student Advisor
The Student Advisor of the MS in Biomedical Management Program is Andrew Bohm, PhD. Dr. Bohm received his PhD in Biophysics from the University of California, Berkeley and completed postdoctoral training at the Lawrence Berkeley Laboratory and Yale University. Dr. Bohm is an Associate Professor in the Department of Developmental, Molecular & Chemical Biology at Tufts University School of Medicine and serves as the Tufts University Postdoctoral Officer. He is a member of the GSBS programs in Cell, Molecular & Developmental Biology and Pharmacology & Drug Development.
Dr. Bohm's research uses X-ray crystallography in conjunction with other biochemical and biophysical techniques to study the structure and function of a variety of proteins and their nucleic acid complexes. His most recent work focuses on creating novel therapeutics to target HIV and HTLV.
Dr. Bohm has mentored numerous students and postdoctoral fellows. Many of his trainees have obtained positions at a variety of companies including Pfizer, New England Biolabs, Alnylam Pharmaceuticals, Techonic Therapeutics, and Seres Therapeutics. He has also done collaborative work with Chiron and New England Biolabs.
Daniel Jay, PhD, Internship Coordinator
Daniel Jay, PhD, serves as the internship coordinator for the MS in Biomedical Management Program. Dr. Jay is the Dean of the Graduate School of Biomedical Sciences and a Professor in the Department of Developmental, Molecular & Chemical Biology at Tufts University School of Medicine. Dr. Jay received his PhD in Biochemistry & Molecular Biology from Harvard University and completed postdoctoral training at the same institution. He is a member of the GSBS programs in Cell, Molecular & Developmental Biology and Neuroscience.
Dr. Jay's research has always focused on developing technologies to solve key biological problems. He developed Chromophore-Assisted Laser Inactivation (CALI) to inactivate specific proteins in living cells at precise times and location and uses this technology to study cancer metastasis. A goal of the approach is to develop improved cancer therapeutics.
Dr. Jay cofounded the German Biotech company Xerion Pharmaceuticals in 1998 and became the chair of their Board of Scientific Advisors in 2004. He has mentored many of his students to leadership in industry.